Martine Rothblatt

Lawyer

Birthday October 10, 1954

Birth Sign Libra

Birthplace Chicago, Illinois, U.S.

Age 69 years old

Nationality United States

#30524 Most Popular

0

Martine Aliana Rothblatt is an American lawyer, author, entrepreneur, and transgender rights advocate.

1954

Rothblatt was born 1954 into a Jewish family in Chicago, Illinois, to Rosa Lee and Hal Rothblatt, a dentist.

She was raised in a suburb of San Diego, California.

Rothblatt left college after two years and traveled throughout Europe, Turkey, Iran, Kenya, and the Seychelles.

1974

It was at the NASA tracking station in the Seychelles, during the summer of 1974, that she had her epiphany to unite the world via satellite communications.

As an undergraduate, she became a convert to Gerard K. O'Neill's "High Frontier" plan for space colonization after analyzing his 1974 Physics Today cover story on the concept as a project for Professor Harland Epps' Topics in Modern Astronomy seminar.

Rothblatt subsequently became an active member of the L5 Society and its Southern California affiliate, the Organization for the Advancement of Space Industrialization and Settlement (OASIS).

During her four-year J.D./M.B.A. program, also at UCLA, she published five articles on the law of satellite communications and prepared a business plan for the Hughes Space and Communications Group titled PanAmSat about how satellite spot beam technology could be used to provide communication service to multiple Latin American countries.

She also became a regular contributor on legal aspects of space colonization to the OASIS newsletter.

1977

She then returned to University of California, Los Angeles (UCLA), graduating summa cum laude in communication studies in 1977, with a thesis on international direct-broadcast satellites.

1981

Rothblatt graduated from University of California, Los Angeles with J.D. and M.B.A. degrees in 1981, then began to work in Washington, D.C., first in the field of communications satellite law, and eventually in life sciences projects like the Human Genome Project.

She is also influential in the field of aviation, particularly electric aviation, as well as with sustainable building.

She is the founder and chairwoman of the board of United Therapeutics.

She was also the CEO of GeoStar and the creator of SiriusXM Satellite Radio.

Upon graduating from UCLA in 1981 with a joint J.D./M.B.A. degree, Rothblatt was hired by the Washington, D.C., law firm of Covington & Burling to represent the television broadcasting industry before the Federal Communications Commission in the areas of direct broadcast satellites and spread spectrum communication.

1982

In 1982, she left to study astronomy at the University of Maryland, College Park, but was soon retained by NASA to obtain FCC approval for the IEEE C band system on its tracking and data relay satellites and by the National Academy of Sciences' Committee on Radio Frequencies to safeguard before the FCC radio astronomy quiet bands used for deep space research.

Later that year she was also retained as vice president by Gerard K. O'Neill to handle business and regulatory matters for her newly invented satellite navigation technology, known as the Geostar System.

Rothblatt is a regulatory attorney.

She also served as a member of the Space Studies Institute (SSI) board of trustees.

1984

In 1984, she was retained by Rene Anselmo, founder of Spanish International Network, to implement her PanAmSat MBA thesis as a new company that would compete with the global telecommunications satellite monopoly, Intelsat.

Rothblatt was responsible for launching several communications satellite companies, including the first private international spacecom project (PanAmSat, 1984), the first global satellite radio network (WorldSpace, 1990), and the first non-geostationary satellite-to-car broadcasting system (Sirius Satellite Radio, 1990).

1986

In 1986, she discontinued her astronomy studies and consulting work to become the full-time CEO of Geostar Corporation, under William E. Simon as chairman.

1987

As an attorney-entrepreneur, Rothblatt was also responsible for leading the efforts to obtain worldwide approval, via new international treaties, of satellite orbit/spectrum allocations for space-based navigation services (1987) and for direct-to-person satellite radio transmissions (1992).

1990

She left Geostar in 1990 to create both WorldSpace and Sirius Satellite Radio.

1992

She left Sirius in 1992 and WorldSpace in 1997 to become the full-time chairman and CEO of American medical biotechnology company United Therapeutics.

1994

In 1994, motivated by her daughter being diagnosed with life-threatening pulmonary hypertension, Rothblatt created the PPH Cure Foundation and in 1996 founded United Therapeutics.

That same year, she says, she had sex reassignment surgery.

At that time she also began studying for a Ph.D. in medical ethics at the Barts and The London School of Medicine and Dentistry, Queen Mary University of London.

1997

Rothblatt helped pioneer airship internet services with her Sky Station project in 1997, together with Alexander Haig.

She then successfully led the effort to get the US Federal Communications Commission (FCC) to allocate frequencies for airship-based internet services.

She also led the International Bar Association's biopolitical project to develop a draft Universal Declaration on the Human Genome and Human Rights for the United Nations (whose final version was adopted by the UNESCO on November 11, 1997, and endorsed by the United Nations General Assembly on December 9, 1998).

Rothblatt is a well-known voice for medical and pharmaceutical innovation.

2001

The degree was granted in June 2001 based upon her dissertation on the conflict between private and public interests in xenotransplantation.

This thesis, defended before England's leading bioethicist John Harris, was later published by Ashgate House under the title Your Life or Mine.

2013

In 2013, Rothblatt was the highest-paid woman CEO in America, earning $38 million.

2018

She was the top earning CEO in the biopharmaceutical industry in 2018.

As of April 2018, Rothblatt earned a compensation package worth $37.1 million from United Therapeutics.

The majority of the compensation package is for stock options.

In January 2022, Rothblatt's company Lung Biotechnology made an attempt at effectuating her Ph.D. dissertation by transplanting the first genetically-modified porcine heart in hopes that it would successfully save the life of a patient.

The recipient subsequently died on Tuesday, March 8, 2022.